Butler John P. (CIK 1591467) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy AKBA (350,000 shares), Buy AKBA (69,270 shares), Sell AKBA (46,660 shares), Sell AKBA (96,065 shares), Sell AKBA (114,891 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Buy | 350,000 | $220,500 |
| 2026-03-05 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Buy | 69,270 | $86,588 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Sell | 46,660 | $64,857 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Sell | 96,065 | $133,530 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Sell | 114,891 | $159,698 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Buy | 175,250 | $247,102 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Sell | 83,689 | $116,328 |
| 2026-02-03 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Buy | 743,000 | $0 |
| 2025-03-04 | Akebia Therapeutics, Inc. (AKBA) | CEO and President | Sell | 46,409 | $84,928 |
Source: SEC Form 4 filings · as of 2026-08-10